Joe Russo Joins AAM as Senior Director, Federal Government Affairs
WASHINGTON, D.C. (August 10, 2021) — Today Joe Russo is joining the Association for Accessible Medicines as Senior Director, Federal Government Affairs. Joe will help develop the association’s strategy and implement the initiatives of AAM’s government affairs department. He is responsible for managing a range of government relations initiatives and projects to promote the federal […]
Joanne Duncan Joins AAM as Chief Operating Officer
WASHINGTON, D.C. (July 28, 2021) — Today Joanne Duncan is joining the Association for Accessible Medicines as Chief Operating Officer. She will be responsible for leading and managing implementation of a more comprehensive member recruitment strategy. She will drive operational improvement by increasing the alignment between issue prioritization and the budgeting process, maximizing IT functionality and […]
Introducing the AAM All Access Podcast
The modern generics and biosimilars industry is one of the great, untold American success stories. Nine out of ten prescriptions are filled with generics, yet they account for only 20% of all spending on medicines. Biosimilars are steadily coming on to the market to bring competition to the expensive brand-name biologics that are at the root of our nation’s prescription drug cost woes. This is an exciting industry that […]
Steven Selde Joins AAM’s Biosimilars Council as Director
WASHINGTON DC (May 24, 2021) – Today Steven Selde is joining the Association for Accessible Medicines (AAM) as Director of the Biosimilars Council. This division of AAM educates the public and patients about the safety and effectiveness of biosimilars, focusing on access, the regulatory environment, reimbursement and legal affairs. Member organizations include manufacturers and stakeholders […]
AAM Names Erik Komendant Senior Vice President, Government Affairs
Veteran Health Care Advocate Will Lead Federal and State Advocacy For Generic and Biosimilar Industry Group WASHINGTON DC (May 24, 2021) – The Association for Accessible Medicines (AAM) today announced that Erik Komendant has been named Senior Vice President, Government Affairs effective immediately. He will be responsible for the vision, strategic planning, and implementation of […]
Monét Stanford Joins AAM as Director, Policy
WASHINGTON, D.C. (May 17, 2021) – Today Monét Stanford is joining the Association for Accessible Medicines (AAM) as Director in the Policy department. She will collaborate with leadership to identify and respond to key policy issues affecting AAM members. Her role also includes developing and managing research opportunities, writing testimony, public comments, policy papers and […]
Adam Fein of Drug Channels to Share Insights at Access! 2021
Join industry expert Adam J. Fein, PhD, as he helps the industry navigate this challenging and dynamic period in U.S. drug channels. During this interactive virtual session, Dr. Fein will explain the key trends reshaping U.S. drug channels, examine the emergence of organized market access channels, highlight business and marketing implications for generic and biosimilar […]
Access! 2021 Is Coming. Here’s What You Need to Know
Access!, AAM’s annual meeting for the generics and biosimilars industry, brings policymakers, influential speakers and industry leaders together to share knowledge and ideas. This year virtual Access! is May 26-27. We’re excited to welcome attendees to Access! at a considerable discount. This is a one-of-a-kind chance to gain insight into the ever-changing landscape of generics […]
Women Continue to Make Health Policy History
Women’s History Month is an opportunity to celebrate the contributions women have made in the arts, science, medicine and business. These achievements build a foundation that men and women today rely on to create new milestones for both personal and professional growth. Today, more women than ever are leading Fortune 500 companies, serving as elected […]
AAM Announces 2021 Board of Directors
WASHINGTON, DC (February 24, 2021) — The Association for Accessible Medicines (AAM) announced the election of its 2021 Board of Directors and Officers today. Mr. Alok Sonig, CEO – US Generics and Global Head – Generics R&D & Biosimilars, Lupin Inc. is the 2021 AAM Chair of the Board. AAM also named Mr. Peter Hardwick, […]
AAM Announces 2021 Associate Members
WASHINGTON, DC (February 24, 2020) — The Association for Accessible Medicines (AAM) is pleased to announce its 2021 Associate Members. Associate Members are entities allied with the interests, needs and policy positions of generic and biosimilar medicine developers. Generic drugs saved the U.S. health system $313 billion in 2019, according to the Generic Drug Access […]
Thank you, Mike Puskar
We at the Association for Accessible Medicines are proud of our rich heritage. The pioneers who forged our industry deserve to be heralded. Some are still with us; some are gone. Please keep reading about them and their contributions to society. Entrepreneur: One who organizes, manages and assumes the risks of an enterprise for the […]
